Testing TQB3019 for advanced blood cancers
Part of Cancer clinical trials.
This trial tests an experimental oral capsule called TQB3019 for people with advanced blood cancers that have come back or not improved with other treatments. The goal is to see if the drug is safe and to find the right dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have a blood cancer (like leukemia or lymphoma) that has come back or hasn't improved with standard treatment
- You have at least one tumor that can be measured on scans
- You are not pregnant or breastfeeding, and you agree to use birth control during the study and for 6 months after
- You cannot have had another cancer (except for certain cured skin cancers, bladder cancer, or cervical cancer) in the last 3 years
- You must be able to swallow pills and not have chronic diarrhea or a bowel blockage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called TQB3205 for people with advanced solid tumors that have not responded to other treatments. The study will check if the drug is safe and how it affects the tumors.
This trial tests an experimental oral capsule (TQB3122) for safety and early signs of effectiveness in people with advanced solid tumors that have not responded to standard therapies. It is for patients who are relatively healthy and have specific cancer types like ovarian, breast, or prostate cancer.
This study tests an experimental pill called TQB3217 for people with advanced solid tumors that haven't responded to usual treatments. The goal is to see if the pill is safe, how it works in the body, and whether it helps shrink or slow the cancer.
This trial tests a new drug, TQB6411, for people with advanced cancers that have not responded to standard treatments. It aims to see if the drug is safe and effective for different tumor types.
This study tests an investigational drug called TQB2922, given as an injection under the skin, for people with advanced non-small cell lung cancer that has not improved with standard treatments. The goal is to see if the drug is safe and helpful.
This trial tests a new drug (TQB2916) combined with standard chemotherapy (gemcitabine and nab-paclitaxel) as a first treatment for metastatic pancreatic cancer. It aims to see if the combination works better than chemo alone.
Hear when a new Advanced Malignant Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.